Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by toniZ1on Mar 01, 2023 12:27pm
62 Views
Post# 35312762

RE:Lol

RE:Lol I don't get why some are still believe the dermal injector nonsense. Its is and was just something to promote to keep investors attracted.... 

The same is true for the raise of the share price - there is no real movement/demand, just a few dollars spent to get it up abit to hopefully attaract some new gamblers...

Still the only thing that counts is the outcome with Shiseido. At least the point of truth is not far away anymore. The only thing that did generate some confidence is that AS bought a bigger chunk. But watch out, his average share price is not that high anymore so if he gets the crowd excited and starts to sell off you should simply exit your position. 

So long, heads up and open your eyes - Cheers 
<< Previous
Bullboard Posts
Next >>